comparemela.com

Latest Breaking News On - Addor capital - Page 6 : comparemela.com

China Money Podcast: Andreessen Horowitz Joins 200+ VC Firms This Week Investing In 84 Chinese Startups

Total0 Listen: China Money Podcast: Andreessen Horowitz Joins 200+ VC Firms This Week Investing In 84 Chinese Startups In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending July 23. Eighty-four Chinese startup and growth-stage companies raised a combined US$2.28 billion over the past five days. Investors in the 84 deals this week include DST Global, General Atlantic, Dawang Capital, Capital Today, Ocean Link, Andreessen Horowitz, GGV Capital, Sequoia Capital China, Addor Capital, Highlight Capital, and CS Capital. And they took stakes in a range of businesses including those involved in dental surgery, robotic automation, analog chip development, e-commerce, medical marketing, autonomous vehicles, and fintech. This is the July 23, 2021 edition of the China Money Podcast where we update you on the news, data, and insights you need for making private equity and venture capital decisions in China

China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China

China Digest: TYK Medicines bags $62m; TAOS Data raises $47m led by Matrix Partners China Source: Jan Antonin Kolar/Unsplash May 24, 2021 TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round led by Sealand Innovation, while TAOS Data has secured $47 million in a Series B round led by Matrix Partners China. TYK Medicines bags nearly $62m Series B+ Chinese biopharmaceutical firm TYK Medicines has garnered nearly 400 million yuan ($62 million) in a Series B+ round of financing led by Sealand Innovation, a 17.6 billion yuan ($2.7 billion) fund owned by Sealand Securities, according to a company statement on Monday. The round also saw participation from Haibang Investment and Zheshang Venture Capital, a Hangzhou-based investment firm that has invested in fresh produce e-commerce platform MissFresh; ride-hailing player Caocao; and cloud video provider Arcvideo Tech, among others.

Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures

Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures Source: Jan Antonin Kolar/Unsplash May 12, 2021 Biopharmaceutical firm Hangzhou DAC Biotech Co., Ltd has announced the completion of a 1 billion yuan ($156 million) Series C round co-led by PE firm Hillhouse Capital’s venture unit GL Ventures. State-backed CITIC Private Equity Funds Management (CPE), and CDG Capital a Hong Kong-based investment firm that has invested in healthcare startups like Innovent, Akeso, and Grail were the co-lead investors, DAC Biotech said in a WeChat post on May 8.  It also attracted new investors including CITIC Securities, healthcare-focussed TigerYeah Capital, and K.Wah Group.

China Digest: Dearer nets $65m; Temasek backs Abiochem

China Digest: Dearer nets $65m; Temasek backs Abiochem Dearer nets $65m in Series B Shanghai-headquartered contact lens manufacturer Dearer has raised 420 million yuan ($65 million) in a Series B round of financing.  State-backed alternative asset manager CITIC Private Equity Funds Management (CPE), Legend Holdings’ investment arm Legend Capital and BioTrack Capital joined the round. Insight Capital made a follow-on investment in the round.  The company will use the proceeds for R&D and mass production of coloured contact lenses, the company said in a statement.  Its early-stage investors include Orient Securities, Borchid Capital,  FOF Capital and eyecare service provider Eyebright.  Temasek invests in Abiochem 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.